NDC 70518-4364-01 - CHLORZOXAZONE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4364
- Requested NDC
- 70518-4364-01
- Package NDCs from labels
- 70518-4364-0, 70518-4364-1, 70518-4364-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-01-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Chlorzoxazone Tablets, USP | REMEDYREPACK INC. | 2026-01-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4364-0 | CHLORZOXAZONE | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 2 | |
| 70518-4364-1 | CHLORZOXAZONE | 60 in 1 BOTTLE, PLASTIC | TABLET | 60 | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CHLORZOXAZONE | CHLORZOXAZONE | A-S Medication Solutions | d0210638-b828-4c05-9669-fd61ef987317 | 2025-02-04 | Warnings, Adverse reactions | 197502 H0DE420U8G |
| Chlorzoxazone | CHLORZOXAZONE | Advanced Rx Pharmacy of Tennessee, LLC | f8ff7293-89b6-b6ee-e053-6394a90a7d39 | 2024-12-31 | Warnings, Adverse reactions | ANDA089853 197502 H0DE420U8G |
| Chlorzoxazone | CHLORZOXAZONE | Bryant Ranch Prepack | 5e6889c9-a091-4622-0a00-ad0fc1830f78 | 2024-10-08 | Warnings, Adverse reactions | 197502 H0DE420U8G |
| CHLORZOXAZONE | CHLORZOXAZONE | Bryant Ranch Prepack | d7f09907-83b2-46cf-947d-fa38dcf88685 | 2024-09-09 | Warnings, Adverse reactions | 197502 H0DE420U8G |
| Chlorzoxazone | CHLORZOXAZONE | Actavis Pharma, Inc. | 2f05e8e2-616f-475b-ac9f-c42e1a5dbe81 | 2024-08-25 | Warnings, Adverse reactions | 197502 H0DE420U8G |
| CHLORZOXAZONE | CHLORZOXAZONE | Bryant Ranch Prepack | 669afcc1-d587-4dc0-8f6e-99109bcfed36 | 2024-04-03 | Warnings, Adverse reactions | ANDA089853 197502 H0DE420U8G |
| Pure Cornstarch Baby | CORN STARCH | Walgreen Company | d0e9bd13-b568-4f7e-b036-8d23e71ad8bf | 2024-03-25 | Warnings | O8232NY3SJ |
| CHLORZOXAZONE | CHLORZOXAZONE | Cintex Services, LLC | 13a1aa33-6971-da5a-e063-6394a90a9e12 | 2024-03-21 | Warnings, Adverse reactions | 197502 H0DE420U8G |
| CHLORZOXAZONE | CHLORZOXAZONE | Aurobindo Pharma Limited | 52d3aa2c-f88f-4de7-b5ae-df8a46e94879 | 2023-09-05 | Warnings, Adverse reactions | ANDA089853 59651-306 1088936 1088934 197502 13956b60-a22d-4ee8-af95-460830ebfbc9 52d3aa2c-f88f-4de7-b5ae-df8a46e94879 H0DE420U8G |
| Chlorzoxazone | CHLORZOXAZONE | Mayne Pharma Commercial LLC | 5238c99e-d36e-4376-ab05-ca2535213d58 | 2023-07-06 | Warnings, Adverse reactions | 1088936 1088934 197502 H0DE420U8G |
| CHLORZOXAZONE | CHLORZOXAZONE | Rising Pharma Holdings, Inc. | 1df6058b-7bf2-4246-9827-93fa023a5fd4 | 2023-06-09 | Warnings, Adverse reactions | 1088936 1088934 197502 H0DE420U8G |
| Chlorzoxazone | CHLORZOXAZONE | Bryant Ranch Prepack | 267a0a2a-b818-47d9-9b61-28be172de99a | 2023-05-25 | Warnings, Adverse reactions | 197502 H0DE420U8G |
| CHLORZOXAZONE | CHLORZOXAZONE | Cintex Services, LLC | c95f39c4-0c11-966a-e053-2a95a90a2c18 | 2023-05-23 | Warnings, Adverse reactions | H0DE420U8G |
| Chlorzoxazone | CHLORZOXAZONE | A-S Medication Solutions | 6c418b8f-4a1c-4611-80d5-3a3a7dbca9c8 | 2023-03-08 | Warnings, Adverse reactions | 197502 H0DE420U8G |
| Refresh Digital PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | 97e83e68-6374-4df4-93f6-d707fc32748d | 2022-11-28 | Warnings | 6OZP39ZG8H |
| Refresh Digital | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | b2bd34d4-fab9-4f4b-9be2-5d30b55f5b81 | 2022-11-28 | Warnings | 6OZP39ZG8H |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | ebd0839e-2e1d-4e0e-986c-19f1f5c76358 | 2022-09-15 | Warnings | 6OZP39ZG8H |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80 | Allergan, Inc. | aaa943e4-7c38-4c5a-b7c0-5a656d8cafc0 | 2022-09-01 | Warnings | 6OZP39ZG8H |
| REFRESH Optive Mega-3 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | c5f2b3f2-2071-45bd-a010-67f848bc0233 | 2022-06-30 | Warnings | 6OZP39ZG8H |
| Chlorzoxazone | CHLORZOXAZONE | Proficient Rx LP | 63338935-f3dd-4ef1-bb66-856a83c95f41 | 2022-04-01 | Warnings, Adverse reactions | 197502 H0DE420U8G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.